Brain and cerebrospinal fluid

CHAPTER 31 Brain and cerebrospinal fluid



Malcolm Galloway, Maria Thom





INTRAOPERATIVE CYTOLOGY OF THE CENTRAL NERVOUS SYSTEM


Malcolm Galloway



Introduction


Tumours of the central nervous system (CNS) account for 1.6% of cancers in England and Wales; however, due to the high mortality of many of the common brain tumours, they account for a substantial burden in years of life lost. The annual incidence of primary CNS tumours in adults in England and Wales is approximately 6500, of which 58% are reported to be ‘malignant’ (WHO grade III or IV).1,2


The current national guidelines for CNS tumours recommend that all patients with brain tumours are cared for by a multidisciplinary team (MDT) with core members including a neuropathologist.1 Patients should be discussed where possible by the MDT prior to surgery to allow selection of cases for intraoperative neuropathological assessment. Intraoperative assessment can be particularly useful when stereotactic biopsies are being taken, to ensure adequate material has been obtained for subsequent definitive histology. Intraoperative pathology can also assist the surgeon in the management of the patient during the operation. In rare cases, the intraoperative assessment may be used to guide postoperative management, while awaiting definitive paraffin section histological diagnosis.



Intraoperative neuropathological techniques


A variety of techniques may be used, including frozen section histology and smears or imprint cytology. Frozen section is superior to smear cytology for the assessment of architectural features; however, smear cytology allows better demonstration of nuclear morphology, which can be particularly useful in distinguishing astrocytic and oligodendroglial neoplasms.3 A danger of using frozen sections is that, although the block used to prepare a frozen section can be retained for subsequent formalin-fixed, paraffin wax embedded sections, tissue that has been previously frozen can show substantial freezing artefact. Cytological techniques are more rapid than frozen sections, and use relatively little tissue. Where there is sufficient material to perform both techniques, they should be considered to be complementary.


Occasionally, brain smears may be used for postmortem diagnosis allowing a more accurate assessment of underlying neuropathology than gross examination alone.



Intraoperative neuropathological cytology techniques


This chapter focuses on smear preparations, which are the most widely used cytological technique in intraoperative neuropathology. An alternative technique is the touch (imprint) cell preparation, which can be useful particularly when the cells within the lesion are discohesive.4


The cytological assessment of fluid from cystic brain lesions may also be performed intraoperatively. However, this has been shown to have a high false negative rate, and, therefore, is not used routinely.5


The smear technique involves placing samples of tissue at one end of a glass slide, pressing on to the tissue with another slide, and sliding it over to produce a thin trail of cellular material. The challenge with the technique is to provide enough pressure on the tissue to produce material as close to a monolayer of cells as is possible, without crushing the cells and producing too much artefact. With experience, the skill of applying the appropriate level of pressure for different types of tumour is acquired. For example a pituitary adenoma usually spreads into a monolayer of cells with minimal pressure, whereas a schwannoma requires considerable pressure and often cutting the sample into small pieces prior to smearing in order to produce an interpretable preparation.


The quantity of tissue used on each smear, and the number of smears made depends on the quantity of tissue available for assessment. If the smear is too thick, the cellularity of the lesion is difficult to assess and nuclear detail is obscured. The more tissue examined, the more likely the examination is to be representative of the whole lesion. However, this may mean that less tissue is available for final histological diagnosis.


Various stains may be suitable for intraoperative smear cytology, the two most commonly used stains are haematoxylin and eosin (H&E) and toluidine blue. H&E staining demonstrates cytoplasmic features, such as astrocytic cell processes well. Toluidine blue is particularly useful for fine nuclear detail, but demonstrates cytoplasmic features less well. Individual preference, experience and local practice will determine whether either or both stains are used.


The tissue used for smear cytology is initially unfixed. This raises health and safety concerns. The procedure should only be carried out in an environment that is suitable for handling potentially infectious material, and appropriate safety clothing should be worn. The smear itself should be made with caution, as occasionally slides may break during the procedure. Rubbery lesions, such as schwannomas and some meningiomas may ‘ping’ out from the slide when compression is applied, potentially posing an ocular hazard.



Cytology of the normal brain


When looking at a brain smear, it is essential to know the approximate location of the lesion. Different parts of the normal brain have very different appearances on smear cytology, and it is important not to misinterpret these as pathological findings. For example, the granular cell layer of the cerebellum smears out as a monolayer of small cells with round nuclei and scanty cytoplasm. This appearance could mimic a lymphocytic infiltrate (Fig. 31.1A). Normal white matter will usually produce a relatively even smear, with low cellularity and evenly spaced out cells (Fig. 31.1B). Smears from the cortex or from deep grey nuclei will show similar features, with interspersed neurones, the size and shape of which will vary depending on the location (Fig. 31.1C). The neuropil in grey matter tends to have a ‘fluffy’ appearance.







Non-neoplastic conditions



Infections


Infections are an important differential diagnosis for intracranial lesions, particularly in immunocompromised patients. Such patients present a particular challenge as abscesses, tumours and progressive multifocal leukoencephalopathy may all produce a similar radiological pattern of a ring-enhancing lesion.


The range of infections that may affect the central nervous system includes parasites, fungi, bacteria, viruses and prions.





Other infections


Parasitic cysts may contain fragments of the parasite which may be of diagnostic utility intraoperatively. The cyst fluid in such cysts will usually contain macrophages and eosinophils.


Toxoplasmosis, due to infection by the parasite Toxoplasma gondii, results in a necrotising infection, usually in immunocompromised patients. On imaging, it produces ring-enhancing lesions that may be mistaken for a neoplasm. On smear, the edge of the lesion may show reactive gliosis and contain chronic inflammatory cells. More central smears also include necrotic debris and neutrophils. If found, the bradyzoites, swollen cells containing numerous Toxoplasma organisms, are diagnostic.


Fungal infection may produce a granulomatous pattern of inflammation. The presence of a mixed inflammatory infiltrate including multinucleated giant cells in a smear should raise the possibility of fungal infection. Although typically the organism will be identified on paraffin sections rather than cytological specimens, fungal elements may be seen on smear. Fungi that infect the central nervous system may produce hyphae (Aspergillus, Mucor), pseudohyphae (Candida), or yeasts (Cryptococcus).7 In histoplasmosis the organisms are characteristically found within macrophages.


The most frequently seen viral infection on intraoperative smear is progressive multifocal demyelinating leukoencephalopathy (see below).


Patients with suspected prion infection should not routinely undergo intraoperative neuropathological assessment, and the tissue should be handled with appropriate decontamination protocols.





Infarction


A typical infarct would not be subject to biopsy; however, infarcts occasionally clinically and radiologically mimic a neoplasm, and may be encountered as intraoperative smears. Approximately 12 hours after an infarct, ischaemic changes can be seen in neurones. These cells become shrunken and eosinophilic. The nuclei of glial cells also degenerate. Within the first 5 days, there is an infiltrate of neutrophils. Later, there will be an infiltrate of foamy macrophages (Fig. 31.4), and adjacent astrocytes will undergo reactive changes. The infarct induces in-growth of newly formed capillaries.



The smear findings will depend on the age of the lesion, and the region of the lesion sampled. The central necrotic zone will smear as poorly cohesive necrotic material. The edge of a well- established lesion will show prominent reactive astrocytes set within a fibrillary stroma.


There is a danger of misidentifying macrophages as neoplastic astrocytes. The presence of foamy, vacuolated cytoplasm suggests that the cells are macrophages.




Tumours


The WHO Classification2 divides tumours of the central nervous system into four grades, with grade I having the most benign natural history, and grade IV the most aggressive. Unfortunately, the traditional concepts of benign and malignant can be difficult to apply meaningfully to tumours of the central nervous system. The adult brain is housed in the bony cranium, with relatively little capacity for deformation by underlying tumour, resulting in the potential for raised intracranial pressure and compression of vital structures, regardless of the degree of histological atypia of the underlying tumour. Thus the prognosis for an individual patient depends on the location of the lesion as well as the histological type and grade. Most glial tumours have an infiltrative nature, which precludes surgical cure.



Diffusely infiltrating astrocytic tumours


Astrocytic tumours are the most common gliomas. They vary enormously in morphological features and clinical outcome, ranging from the relatively benign pilocytic astrocytoma (WHO grade I), a circumscribed childhood tumour, to the most frequent type of astrocytic tumour, glioblastoma (WHO grade IV).


Grade II, III and IV astrocytic tumours typically have an infiltrative biology, and by the time of presentation have usually crept along nerve fibre pathways far beyond what appears to be the edge of the tumour on imaging. The diffusely infiltrating astrocytic tumours are not usually amenable to curative therapy.


Glioblastoma may arise de novo (primary glioblastoma) without any previous history to suggest a lower grade precursor tumour, or may evolve from a diffusely infiltrating astrocytoma (WHO grade II) or anaplastic astrocytoma (WHO grade III) (Fig. 31.5). It is very rare for pilocytic astrocytoma to transform into a higher grade lesion, and if the clinical history suggests such a transformation, cautious review of the original biopsy would be warranted.




Glioblastoma


Glioblastoma, also known as glioblastoma multiforme is, as its name suggests, a tumour characterised by a wide variety of morphologies, both between different tumours, and within the same tumour. It is defined as a WHO grade IV, diffusely infiltrating astrocytic tumour with nuclear pleomorphism, mitotic activity and necrosis and/or vascular endothelial hyperplasia.


Glioblastomas range from tumours composed of small cells with high nuclear/cytoplasmic ratio and relatively little specific evidence of differentiation (Fig. 31.6A), to giant cell forms with abundant GFAP-positive cytoplasm (Fig. 31.6B). Many are somewhere between these two extremes, consisting of moderate sized cells with elongated nuclei set within a fibrillary stroma (Fig. 31.6C). On intraoperative smear the full range of morphology seen on histology can be represented. Polarisation may help to reveal a fibrillary stroma, which should have a finer texture than the vessel associated collagen, which may be more prominent. Mitotic activity, necrosis and vascular endothelial hyperplasia are all supportive features (Fig. 31.6D); however, such features may not be seen, which may be due to sampling artifact, and their absence is not diagnostic of a low-grade tumour. In some cases it may only be possible to diagnose an astrocytic tumour, with grading awaiting paraffin sections.





Diffuse astrocytoma, WHO grade II


Grade II diffusely infiltrating astrocytomas are usually slowly growing tumours in young adults. They tend to transform to anaplastic astrocytoma or glioblastoma.


There are several morphological variants of diffuse astrocytoma: fibrillary astrocytoma, gemistocytic astrocytoma and protoplasmic astrocytoma. The most common form is fibrillary astrocytoma, in which astrocytic cells with mildly atypical nuclei and poorly discernible cytoplasm are set within a fibrillary stroma (Fig. 31.7A). The stroma is often microcystic. Mitotic activity is minimal, and necrosis and vascular endothelial hyperplasia absent. On smear, the fibrillary stroma is prominent. The cellularity may be only slightly greater than that of normal brain, and in some cases it may be necessary to wait for paraffin sections to confirm neoplasia.



Gemistocytic astrocytomas contain prominent astrocytes with abundant eccentric eosinophilic cytoplasm. This subtype of astrocytoma, while remaining grade II, has a more aggressive natural history than other types of grade II astrocytoma. The gemistocytic cells are prominent in smears (Fig. 31.7B).


Protoplasmic astrocytoma is a rare subtype composed of astrocytes with monomorphous rounded nuclei and scanty cytoplasm with few processes, set within a stroma rich in mucoid microcysts.2




Anaplastic astrocytoma, WHO grade III


Anaplastic astrocytoma, WHO grade III, shows features of a diffusely infiltrating astrocytic tumour, set within a fibrillary stroma; however, mitotic activity is more prominent than in a grade II astrocytoma (Fig. 31.7). The WHO Classification is vague about the mitotic rate cut-off between grade II and III astrocytic tumours (which may be reasonable as the distinction is an arbitrary definition within a spectrum of malignancy). Finding any identifiable mitotic figures in a smear should raise concern regarding atypia, and if more than one or two mitoses are seen, I would regard this as favouring anaplasia. Necrosis and vascular endothelial hyperplasia (in the absence of previous intervention) are not present by definition.




Circumscribed astrocytic tumours


Unfortunately, the most common glial tumours are diffusely infiltrative and not amenable to curative treatment. A less frequent group of gliomas (including pilocytic astrocytoma and pleomorphic xanthoastrocytoma) have a circumscribed growth pattern, and a much more favourable prognosis. Recognition of these entities is vital in order to reliably predict prognosis and offer appropriate therapy.


The circumscribed gliomas are often difficult to distinguish from diffusely infiltrative gliomas intraoperatively on cytological grounds alone, however, the age of the patient and the radiological findings should encourage consideration of a lower grade diagnosis.






Oligodendroglioma


Oligodendrogliomas are less common than astrocytic tumours. They are typically cerebral tumours in adults. Most oligodendrogliomas are WHO grade II tumours; however, they may evolve into, or present de novo, as anaplastic oligodendroglioma, WHO grade III. Oligodendrogliomas are frequently calcified, which can produce a gritty feel when performing the smear;9 however, calcification is not seen in all oligodendrogliomas, and not all calcified gliomas are oligodendroglial.


The characteristic hallmark of oligodendroglioma in paraffin sections is the prominent zone of perinuclear clearing. This is a fixation artefact, and is not usually seen in smears or frozen sections, making diagnosis more difficult. The smear should, however, show a fine network of thin-walled capillaries with a wide branching angle, tumour cells with rounded nuclei and mildly clumped chromatin, and (in contrast to astrocytic tumours) little fibrillary stroma (Fig. 31.9A). The tumour cells usually have scanty cytoplasm; however, a population of ‘mini-gemistocytes’, cells with rounded nuclei and a bulge of glial fibrillary acidic protein containing cytoplasm without extensive processes may be seen. Oligodendrogliomas are frequently calcified; however, calcification is not seen in all oligodendrogliomas, and not all calcified gliomas are oligodendroglial.



Typical grade II oligodendrogliomas do not show necrosis or vascular endothelial hyperplasia, and mitotic activity is minimal. Anaplastic oligodendrogliomas, WHO grade III have more irregular, hyperchromatic nuclei with coarser chromatin, show substantial mitotic activity, and may show necrosis and/or vascular endothelial hyperplasia. The cytoplasm may be more prominent in anaplastic oligodendrogliomas, and the nuclei less round, and there is a spectrum of smear morphology between anaplastic oligodendroglioma and malignant astrocytic tumours (Fig. 31.9B). Definite diagnosis in such cases may require paraffin sections, and may depend on cytogenetic testing for loss of regions of chromosomes 1p and 19q (a pattern typical of oligodendroglial tumours).




Ependymoma


Ependymomas are typically slowly growing tumours in children and young adults, arising around the ventricles or in the spinal cord. They are usually WHO grade II; however, an anaplastic grade III variant occurs, as do the grade I variants myxopapillary ependymoma (in the cauda equina region) and subependymoma.2


The ependymal rosette is a specific structure in which columnar cells are arranged around a central lumen; however, this structure is not seen on paraffin sections in the majority of ependymomas, and is even less frequently identified intraoperatively. Perivascular pseudorosettes, in which processes from tumour cells converge on blood vessels, are much more frequently seen, but are less specific.


Ependymomas are usually moderately cellular, and have monomorphous oval nuclei with granular chromatin. Nuclear grooves have been reported to be more frequent in ependymoma than in other common brain tumours.12


There are subtypes of ependymoma which may cause difficulties on smear diagnosis. Papillary ependymomas could be mistaken for carcinomas or choroid plexus tumours. Clear cell ependymomas may be mistaken for oligodendrogliomas or central neurocytomas. Tanycytic ependymomas may closely resemble astrocytomas.




Tumours showing neuronal differentiation


Tumours consisting entirely or partially of cells showing neuronal differentiation range from highly malignant tumours containing cells with a primitive appearance, such as medulloblastoma, to relatively indolent tumours with large, well-differentiated ganglion cells such as gangliocytoma and ganglioglioma.



Primitive neuroectodermal tumours


Primitive neuroectodermal tumours (PNETs) are WHO grade IV tumours predominantly found in children. The most frequent subtype is the cerebellar medulloblastoma; however, supratentorial PNETs are also found, and PNETs are occasionally seen in adults.


PNETs are highly cellular, malignant tumours, with immunocytochemical and sometimes morphological evidence of primitive neuronal differentiation. They may also concurrently show evidence of glial differentiation.


PNETs usually smear as densely cellular monolayers with oval or carrot-shaped nuclei and scanty cytoplasm (Fig. 31.10).13 The chromatin pattern is finely granular, and the nuclei are moderately pleomorphic. Mitotic activity may be prominent, and necrosis may be seen. Neuroblastic rosettes may be identified.



Given the cerebellar location of many PNETs great care should be taken not to confuse cerebellar granular cell neurones with neoplastic medulloblastoma cells. The cells of a medulloblastoma are usually larger than cerebellar granule cell neurones, more pleomorphic, and mitotically active.


In older adult patients metastatic small cell carcinoma and small cell glioblastoma may produce a similar appearance, and are statistically much more frequent than PNET in this age group.




Ganglioglioma/gangliocytoma, WHO grade I


Tumours partially or exclusively composed of neurons with a mature appearance are typically found in the cerebral cortex of young patients with seizures. The neurons are usually large, atypical, and may be binucleate. In gangliocytomas the neoplastic ganglion cells are the only neoplastic component of the tumour. Gangliogliomas contain an additional neoplastic glial component. Calcification and a perivascular chronic inflammatory reaction are often seen. There is frequent subarachnoid involvement of the tumour, which can induce a fibrous response, making smearing difficult.


It may be difficult on a smear to differentiate between an astrocytic tumour infiltrating grey matter and a ganglioglioma. Often the cytoplasm of the neoplastic neurons will be damaged by the smearing process, leaving large bare nuclei with prominent nucleoli. If preserved, the cytoplasm of the ganglion cells may be abundant, and abnormal processes may be seen.


There is a rare malignant variant of ganglioglioma in which there is frank anaplasia of the neoplastic glial component (anaplastic ganglioglioma, WHO grade III).





Dysembryoplastic neuroepithelial tumour


Dysembryoplastic neuroepithelial tumour (DNET) is a benign tumour characteristically found in the temporal cortex of children and younger adults with partial seizures. The characteristic feature of the tumour is the ‘specific glioneuronal element’, in which parallel bundles of axons are surrounded by cells with small rounded nuclei, resembling oligodendrocytes. ‘Floating neurons’ are present in the matrix between these columns. Many cases are associated with cortical dysplasia in adjacent cortex.


DNET has been divided into simple and complex forms depending on the architecture. The simple form shows the glioneuronal element, without additional cellular elements. The complex form includes both the glioneuronal element and glial nodules. The tumour may include areas with astrocytic, oligodendroglial and/or neuronal differentiation.


Given the vast range of architecture and morphology that can be associated with the diagnosis of DNET, the diagnosis may be difficult to make on small biopsies. The differential diagnosis may include oligodendroglioma, astrocytic tumours and ganglioglioma.


The situation is even more difficult on intraoperative smear. In an appropriate clinical and radiological context finding a population of small, round oligodendroglial-like cells associated with spaces containing ‘floating neurons’ on a smear would be supportive of a diagnosis of DNET.17 Great caution should be exercised in making such a diagnosis in the absence of supportive clinical/radiological features. It is very difficult to reliably establish intraoperatively whether a neurone is a ‘floating neurone’ in a DNET, or whether the neurone is an entrapped non-neoplastic neurone at the edge of a diffusely infiltrating glioma.





Meningioma


A durally attached tumour compressing the brain or spinal cord, without directly infiltrating the brain will usually be a meningioma. Most meningiomas are low-grade (WHO grade I) tumours, which if surgically accessible can be cured by excision. In some cases, either due to recurrence, higher grade, brain invasion and/or incomplete excision, radiotherapy may be necessary. A minority of meningiomas are considered histologically atypical, and are associated with a more aggressive natural history, and regarded as WHO grade II. A very small minority show histological features of frank anaplasia, mimicking carcinoma, sarcoma, melanoma or lymphoma, and are regarded as WHO grade III lesions.


There are currently 15 histological subtypes of meningioma recognised by the WHO Classification.2 Nine of the subtypes are by definition WHO grade I (meningothelial, fibrous, transitional, psammomatous, angiomatous, microcystic, secretory, lymphoplasmacyte-rich, metaplastic). Three subtypes are defined as grade II (chordoid, clear cell, atypical), and three as WHO grade III (papillary, rhabdoid, anaplastic).


Particularly useful features on smear are lobules (Fig. 31.12A) and whorls of meningothelial cells (Fig. 31.12B) and psammoma bodies (Fig. 31.12C).



The features used to define atypia (WHO grade II) are increased mitotic activity (four or more mitoses/10×40 high- power fields) or three or more of the following: foci of small cells with a high nuclear/cytoplasmic ratio, prominence of nucleoli, sheet-like architecture, and focal necrosis.


It should be noted that nuclear pleomorphism, a feature that may be striking in some meningioma smears, is not part of the diagnostic criteria for atypia. Figure 31.12D shows a smear of a durally-based tumour which had prominent nuclear pleomorphism, raising the possibility of a sarcoma, metastatic tumour, or of a higher grade meningioma. Although there was a hint of lobularity in this case, nucleoli were only small, and mitotic activity was inconspicuous. In such a case it is not possible to give a definite report of meningioma intraoperatively, and paraffin sections are required to judge the architecture and immunophenotype. In this case paraffin sections confirmed a microcystic meningioma, WHO grade I. It is common for microcystic and angiomatous meningiomas to show a greater degree of nuclear pleomorphism than would be expected for their grade or degree of mitotic activity.


Intranuclear pseudoinclusions are often described as typical of meningiomas, and are frequently encountered in meningiomas, both in intraoperative smears, and in histological sections; however, they may not be either as specific or as sensitive as appears to be generally believed. Not all meningiomas have intranuclear pseudoinclusions, and some other tumours (including gliomas and extraskeletal myxoid chondrosarcoma) may contain them.


The reactive lymphocytic and plasma cell infiltrate in a lymphoplasmacytic meningioma may almost entirely obscure the neoplastic component, and may mimic a lymphoma or an infectious/inflammatory process.


A chordoid background and architecture would be expected in chordoid meningioma, although there should also be areas of tumour with a more typically meningioma-like morphology. Such a tumour may mimic chordoma and, depending on location, chordoid glioma.


Papillary meningiomas are a rare subtype characterised by pseudopapillary architecture, and aggressive behaviour, leading to systemic metastasis in approximately 20% of patients.2 Papillary meningiomas may mimic other papillary/pseudopapillary tumours (such as metastatic papillary carcinoma and choroid plexus tumours). Intraoperatively it would usually only be possible to report such a lesion as a papillary tumour, which, given the location, would be compatible with a papillary meningioma, and await paraffin sections and immunocytochemistry for further assessment.



Jun 8, 2017 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Brain and cerebrospinal fluid

Full access? Get Clinical Tree

Get Clinical Tree app for offline access